Form 8-K - Current report:
SEC Accession No. 0000944809-21-000038
Filing Date
2021-05-21
Accepted
2021-05-21 16:56:20
Documents
12
Period of Report
2021-05-17
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K opk-20210517.htm   iXBRL 8-K 41294
  Complete submission text file 0000944809-21-000038.txt   179055

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210517.xsd EX-101.SCH 1941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210517_lab.xml EX-101.LAB 24275
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210517_pre.xml EX-101.PRE 12676
5 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210517_htm.xml XML 10758
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 21949851
SIC: 2834 Pharmaceutical Preparations